Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:35:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:30:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Access to the NCT03703050 study record is blocked by a 403 Forbidden page, replacing the previous study content. The page no longer shows the study details, locations, and related submission history, preventing users from viewing the trial information.
    Difference
    18%
    Check dated 2026-09-21T21:49:25.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a newer revision tag, Revision: v3.6.6, replacing the previous v3.6.5. This reflects an update to the page's version metadata rather than substantive changes to study details or layout.
    Difference
    0.1%
    Check dated 2026-08-31T16:29:22.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a line '2018 ( U.S. NIH Grant/Contract )' to the study identifiers, indicating NIH grant attribution for this trial.
    Difference
    0.1%
    Check dated 2026-08-24T17:34:18.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.4 to v3.6.5, representing a refreshed edition of the page. No substantive study information or navigation changes are indicated by this update.
    Difference
    0.1%
    Check dated 2026-08-10T11:39:07.000Z thumbnail image

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.